ConductScience.org, home

Paper24944397

Combination therapy for chronic invasive rhinocerebral aspergillosis in a clinically immunocompetent patient.

Lujber L and 3 others. Curr Ther Res Clin Exp, 2003. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Combination therapy for chronic invasive rhinocerebral aspergillosis in a clinically immunocompetent patient. Papers, record 24944397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24944397

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combination therapy for chronic invasive rhinocerebral aspergillosis in a clinically immunocompetent patient.
PubMed
Journal
Curr Ther Res Clin Exp
PubMed
Year
2003
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.15
iCite
Revised in PubMed
2024-03-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lujber LLászló
2Gerlinger IImre
3Kuncz AAdám
4Pytel JJózsef

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110338518Interleukin-12 enhances antifungal activity of human mononuclear phagocytes against Aspergillus fumigatus: implications for a gamma interferon-independent pathway.Infect Immun1999https://conductscience.org/library/papers/10338518PubMed
24159725Aspergilloma of paranasal sinuses and orbit in Northern Sudanese.Lancet1966https://conductscience.org/library/papers/4159725PubMed
34200814Further observations on the primary paranasal aspergillus granuloma in the Sudan: a morphological study of 46 cases.Am J Trop Med Hyg1973https://conductscience.org/library/papers/4200814PubMed
48722837The new fungal opportunists are coming.Clin Infect Dis1996https://conductscience.org/library/papers/8722837PubMed
58879787Therapeutic outcome in invasive aspergillosis.Clin Infect Dis1996https://conductscience.org/library/papers/8879787PubMed
63174990Fungal sinusitis: diagnosis with CT and MR imaging.Radiology1988https://conductscience.org/library/papers/3174990PubMed
71309690In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.Diagn Microbiol Infect Dis1992https://conductscience.org/library/papers/1309690PubMed
87596522Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole, and radical surgery--case report and review of the literature.Neurosurgery1995https://conductscience.org/library/papers/7596522PubMed
93393078Chronic fungal sinusitis in apparently normal hosts.Medicine (Baltimore)1988https://conductscience.org/library/papers/3393078PubMed
101479276Rhinocerebral aspergillosis.J Laryngol Otol1992https://conductscience.org/library/papers/1479276PubMed
117681040Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon.Infect Immun1993https://conductscience.org/library/papers/7681040PubMed
127948573Epidemiology and control of fungal infections.Clin Infect Dis1994https://conductscience.org/library/papers/7948573PubMed
1310770732Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.Clin Infect Dis2000https://conductscience.org/library/papers/10770732PubMed
147598304Interferon-gamma in the management of infectious diseases.Ann Intern Med1995https://conductscience.org/library/papers/7598304PubMed
155773753Primary aspergilloma of paranasal sinuses in the Sudan. A review of seventeen cases.Br J Surg1969https://conductscience.org/library/papers/5773753PubMed
163142124Primary paranasal Aspergillus granuloma in Saudi Arabia.Trop Geogr Med1988https://conductscience.org/library/papers/3142124PubMed
173189365Aggressive combined modality treatment of progressive sinonasal fungal infections in immunocompromised patients.Am J Med1988https://conductscience.org/library/papers/3189365PubMed
186375518Aspergillosis of the paranasal sinuses x-ray diagnosis, histopathology, and clinical aspects.Ann Otol Rhinol Laryngol1984https://conductscience.org/library/papers/6375518PubMed
198890991Cranial and intracranial aspergillosis of sino-nasal origin. Report of nine cases.Acta Neurochir (Wien)1996https://conductscience.org/library/papers/8890991PubMed
209792309Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections.Br J Haematol1998https://conductscience.org/library/papers/9792309PubMed

See all 25 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn Papers
36381625Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu GM-CSF) as Adjuvant Therapy for Invasive Fungal Diseases.Open Forum Infect Dis2022https://conductscience.org/library/papers/36381625

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24944397

GET https://conductscience.org/api/papers/v1/24944397/references?page=2